The 2022 Inflation Reduction Act (IRA) has introduced significant challenges for the pharmaceutical industry, altering the ...

Gilead Sciences (NASDAQ:GILD) and Terray Therapeutics have entered into a strategic collaboration to discover and develop ...

Life sciences companies are the backbone of our local economy and develop life-changing medications and therapies for ...

Scientists from the Miller School of Medicine at the University of Miami have reported their recent work to develop small-molecule inhibitors of the CD40-CD40L (CD154) costimulatory protein-protein ...

The new gene therapies for sickle cell disease—including the gene-editing treatment Casgevy, based on research at Boston ...

DeepCure, a therapeutics company using AI to discover novel therapies for inflammation and immune diseases, announced today ...

CORXEL expands its cardiometabolic pipeline into obesity and diabetesNEW JERSEY and SHANGHAI, Dec. 23, 2024 (GLOBE NEWSWIRE) -- (CORXEL), a leading biotech company committed to bringing innovative ...

Merck & Co. Inc. has turned to Asia for a second time to get into the GLP-1 market, this time to Shanghai-based Hansoh ...

Two types of amylin-based treatments for the treatment of obesity are currently being developed: dual amylin and calcitonin receptor agonists (DACRAs) that target both the amylin and calcitonin ...